2026-06-14T03:54:28Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/168532024-09-27T09:45:14Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Agusti, Alvar author Böhm, Michael author Celli, Bartolomé author Criner, Gerard J author Garcia-Alvarez, Ana author Martinez, Fernando author Sin, Don D author Vogelmeier, Claus F author 2023-05-26 Many patients seen by cardiologists suffer chronic obstructive pulmonary disease (COPD) in addition to their primary cardiovascular problem. Yet, quite often COPD has not been diagnosed and, consequently, patients have not been treated of their pulmonary disease. Recognizing and treating COPD in patients with CVDs is important because optimal treatment of the COPD carries important benefits on cardiovascular outcomes. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) publishes an annual report that serves as a clinical guideline for the diagnosis and management of COPD around the world and has very recently released the 2023 annual report. Here, we provide a summary of the GOLD 2023 recommendations that highlights those aspects of more interest for practicing cardiologists dealing with patients with CVD who may suffer COPD. Clin Res Cardiol. 2023 May 26:1-10. 10.1007/s00392-023-02217-0 1861-0692 Clinical research in cardiology : official journal of the German Cardiac Society 37233751 http://hdl.handle.net/20.500.12105/16853 GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists.